Bertoletti Antonio, Tan Anthony T, Le Bert Nina
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Singapore Immunology Network, A*STAR, Singapore.
Oxf Open Immunol. 2021 Feb 23;2(1):iqab006. doi: 10.1093/oxfimm/iqab006. eCollection 2021.
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), the etiological agent of Coronavirus Diseases 2019 (COVID-19), triggers an adaptive immunity in the infected host that results in the production of virus-specific antibodies and T cells. Although kinetic and quantitative aspects of antibodies have been analyzed in large patient cohorts, similar information about SARS-CoV-2-specific T cells are scarce. We summarize the available knowledge of quantitative and temporal features of the SARS-CoV-2 T-cell response in this review. Currently, most of the data are derived only from the analysis of the circulatory compartment. Despite this limitation, early appearance, multi-specificity and functionality of SARS-CoV-2-specific T cells are associated with accelerated viral clearance and with protection from severe COVID-19.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是2019冠状病毒病(COVID-19)的病原体,它在受感染宿主中引发适应性免疫,从而产生病毒特异性抗体和T细胞。尽管已在大量患者队列中分析了抗体的动力学和定量方面,但关于SARS-CoV-2特异性T细胞的类似信息却很少。在本综述中,我们总结了SARS-CoV-2 T细胞反应的定量和时间特征的现有知识。目前,大多数数据仅来自循环区室的分析。尽管有此局限性,但SARS-CoV-2特异性T细胞的早期出现、多特异性和功能与病毒清除加速以及预防严重COVID-19相关。